Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Birth Control Methods01:22

Birth Control Methods

Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Transdermal Drug Delivery Systems01:18

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks.

American journal of clinical dermatology·2025
Same author

Lichen Sclerosus-A Call for an Evidence-Based Approach.

JAMA dermatology·2025
Same author

Is Upadacitinib Cardioprotective in Chronic Inflammatory Diseases? A Review of Major Adverse Cardiovascular Events and Venous Thromboembolism in Atopic Dermatitis

Journal of drugs in dermatology : JDD·2025
Same author

Tapinarof cream 1% once daily was well tolerated in adults and children with atopic dermatitis in two phase 3 randomized trials.

The Journal of dermatological treatment·2025
Same author

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.

JAMA dermatology·2023
Same author

Lanolin Allergic Reactions: North American Contact Dermatitis Group Experience, 2001 to 2018.

Dermatitis : contact, atopic, occupational, drug·2022
Same journal

Localized radiation therapy provides more durable disease control than topical steroids in stage IA mycosis fungoides.

Journal of the American Academy of Dermatology·2026
Same journal

Atypical fibroxanthoma, pleomorphic dermal sarcoma, and undifferentiated sarcoma: Updates on diagnosis, management, and surveillance.

Journal of the American Academy of Dermatology·2026
Same journal

Response to Li et al., "Comment on Nie et al. (2026) 'Suicidality Reports in Acne Patients Treated with Isotretinoin and Concomitant Antidepressants: A Descriptive Analysis of FDA Adverse Event Reporting System Data'".

Journal of the American Academy of Dermatology·2026
Same journal

Treatment Utilization Patterns in Cutaneous Lupus Erythematosus: A Single-Center Retrospective Analysis.

Journal of the American Academy of Dermatology·2026
Same journal

Hypoactive Sexual Desire Disorder in Menopausal Women: Dermatologic Implications of Antiandrogen and Testosterone Therapy.

Journal of the American Academy of Dermatology·2026
Same journal

Incise parallel, section perpendicular to the dermatoglyphs for diagnosis of acral melanocytic lesions-A comment on Thakker et al.

Journal of the American Academy of Dermatology·2026
See all related articles

Related Experiment Video

Updated: May 15, 2026

Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma
04:12

Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma

Published on: January 19, 2024

Contraception and the dermatologist.

Kelly H Tyler1, Matthew J Zirwas

  • 1Division of Dermatology, Ohio State University, Columbus, Ohio, USA. hoskins.kelly@gmail.com

Journal of the American Academy of Dermatology
|January 22, 2013
PubMed
Summary
This summary is machine-generated.

Dermatologists utilize contraceptives for acne treatment and managing teratogenic medications. Combined oral contraceptives often improve acne, but progestin type influences effectiveness, and some long-acting contraceptives may worsen acne.

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Related Experiment Videos

Last Updated: May 15, 2026

Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma
04:12

Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma

Published on: January 19, 2024

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Area of Science:

  • Dermatology
  • Endocrinology
  • Pharmacology

Background:

  • Contraceptives play a crucial role in dermatological practice, particularly concerning acne management and patient safety during teratogenic treatments.
  • Understanding the dermatological implications of various contraceptive agents is essential for effective patient care.

Purpose of the Study:

  • To outline the key instances where dermatologists encounter contraceptives: acne treatment, contraception for teratogen use, and counseling on acne-exacerbating contraceptives.
  • To review the efficacy of combined oral contraceptives (COCs) for acne and discuss factors influencing their effectiveness, such as progestin content.
  • To highlight the role of long-acting reversible contraceptives (LARCs) in women on teratogenic medications and their potential impact on acne.

Main Methods:

  • Literature review and synthesis of current clinical guidelines and research on contraceptives and their dermatological effects.
  • Analysis of the hormonal components of COCs and LARCs, focusing on progestins and their androgenic or anti-androgenic activity.
  • Clinical considerations for prescribing and counseling patients regarding contraceptive use in the context of dermatological conditions.

Main Results:

  • Most modern COCs demonstrate a beneficial effect on acne, with variations in efficacy linked to the specific progestin component.
  • LARCs are recommended as first-line contraception for women on teratogenic medications.
  • Certain LARCs containing progestins can potentially exacerbate acne, necessitating careful patient selection and counseling.

Conclusions:

  • Dermatologists must be knowledgeable about the dual role of contraceptives in treating acne and preventing pregnancy with teratogenic drugs.
  • The choice of progestin in COCs significantly impacts their efficacy for acne treatment.
  • Careful consideration of LARC formulations is needed to avoid worsening acne in patients requiring contraception for teratogen use.